Atlas Trials

Arpida AG

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Arpida AG

RecordFirmDate
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia (NCT00543608)Arpida AG2007-11-01
Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2) (NCT00303550)Arpida AG2006-03-01
Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1) (NCT00299520)Arpida AG2005-06-01

Track Arpida AG automatically

Every clearance here is in the API, with alerts when new ones post.